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Abstract
Significance: The oxidative process of disulfide-bond formation is essential for the folding of most secretory and
membrane proteins in the endoplasmic reticulum (ER). It is driven by electron relay pathways that transfer two
electrons derived from the fusion of two adjacent cysteinyl side chains onto various types of chemical oxidants.
The conserved, ER-resident endoplasmic oxidoreductin 1 (Ero1) sulfhydryl oxidases that reduce molecular
oxygen to generate an active-site disulfide represent one of these pathways. In mammals, two family members
exist, Ero1a and Ero1b. Recent Advances: The two mammalian Ero1 enzymes differ in transcriptional and post-
translational regulation, tissue distribution, and catalytic turnover. A specific protein–protein interaction be-
tween either isoform and protein disulfide isomerase (PDI) facilitates the propagation of disulfides from Ero1 via
PDI to nascent polypeptides, and inbuilt oxidative shutdown mechanisms in Ero1a and Ero1b prevent excessive
oxidation of PDI. Critical Issues: Besides disulfide-bond generation, Ero1a also regulates calcium release from
the ER and the secretion of disulfide-linked oligomers through its reversible association with the chaperone
ERp44. This review explores the functional repertoire and possible redundancy of mammalian Ero1 enzymes.
Future Directions: Systematic analyses of different knockout mouse models will be the most promising strategy
to shed new light on unique and tissue-specific roles of Ero1a and Ero1b. Moreover, in-depth characterization of
the known physical interactions of Ero1 with peroxidases and PDI family members will help broaden our
functional and mechanistic understanding of Ero1 enzymes. Antioxid. Redox Signal. 16, 1109–1118.
Introduction: Primary Lessons from Yeast
A common characteristic of a vast majority of secretoryand membrane proteins is their need to form disulfide
bonds. These covalent linkages, generated between two cys-
teine side chains by dehydrogenation (oxidation), can either
be located within a single polypeptide chain (intramolecular
disulfide) or connect two proteins to form dimeric/oligomeric
complexes (intermolecular disulfide). Disulfide bonds often
play a pivotal role in promoting proper folding of native
polypeptide chains entering the endoplasmic reticulum (ER)
and in stabilizing the structure of folded proteins destined for
the secretory system. An elaborate enzymatic machinery that
is responsible for oxidative protein folding, that is, the intro-
duction of disulfide bonds into folding substrates, is present
in the ER of all eukaryotic organisms. During this process,
disulfide bonds move from one pair of cysteines to another
(Fig. 1). These thiol-disulfide exchange reactions are orches-
trated by a specialized family of disulfide carrier enzymes, the
protein disulfide isomerases (PDIs) (5). Importantly though,
the ER is also capable of generating disulfide bonds de novo.
While several pathways that can convert diverse types of
oxidants into disulfides exist in parallel (13), this review—
along with a review by Araki and Inaba that elaborately
works out the structural and evolutionary point of view (8)—
will discuss endoplasmic oxidoreductin 1 (Ero1) enzymes,
which usemolecular oxygen (O2) as electron acceptor (and are
therefore termed ‘‘oxidases’’).
ERO1 has first been described in baker’s yeast as an essential
gene (20, 44). Its product Ero1p is an ER-resident glycoprotein
and a critical determinant for the oxidizing capacity of the yeast
cell (20, 44). It possesses two redox-active di-cysteine active
sites. The ‘‘inner active site’’ is oxidized by a proximally bound
flavin adenine dinucleotide (FAD) cofactor (25, 50), which itself
receives oxidizing equivalents by reducing O2 to hydrogen
peroxide (H2O2) (26). The resulting disulfide bond is then
transferred from the core of the protein to the ‘‘outer active site’’
(47), which is located in a flexible peptide loop (25).Via its outer
active site—also termed the ‘‘shuttle disulfide’’—Ero1p can
directly and specifically oxidize one of the two active-site cys-
teine pairs in PDI, the archetypalmember of the PDI family (21,
22, 50). This disulfide relay fromEro1p to PDI enables oxidized
PDI to subsequently introduce disulfide bonds into folding
substrates (Fig. 2) (21, 50).
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Since the resolution of mismatched substrate disulfides
by reduced PDIs is a fundamental component of oxidative
protein folding, an unregulated (hyper-) oxidation of PDI
by Ero1p would be undesirable. Thus, a redox-sensitive
shutdown mechanism represented by noncatalytic, intra-
molecular disulfide bonds effectively impairs Ero1p activity
(27, 48). As the oxidation state of these cysteine pairs is con-
trolled by the ER redox poise, a regulatory feedback loop
ensues in which Ero1p is solely active when new disulfides
are required (48). Taken together, many of the conserved
features of Ero1 sulfhydryl oxidases including their fold,
mechanism of action, physiological relevance, substrate
specificity, and the principle of their tunable activation status
have been unraveled in experiments with the yeast enzyme.
What Yeast Has Failed to Teach Us
Orthologs of Ero1p exist in all eukaryotes (8). Mammalian
genomes harbor two Ero1-like genes, ERO1L and ERO1LB,
which encode Ero1a and Ero1b, respectively (14, 42), and will
be the subject of this review. Interestingly, the study of Ero1a
and Ero1b has not only unveiled many parallels to the yeast
enzyme, but also a number of important differences. Most
prominent among these, themammalian Ero1 genes appear to
be nonessential, as evidenced by the viability of mice carrying
mutated copies of both ERO1L and ERO1LB (55). Themutated
genes feature an intronic ‘‘gene trapping’’ insertion containing
a strong viral splice acceptor. As a consequence, the vast
majority of mRNAs derived from the ERO1L/ERO1LB loci
will give rise to nonfunctional, truncated proteins.
Lipopolysaccharide-activated spleen cells (LPS blasts) iso-
lated from the mutant mice are nearly indistinguishable from
their wild-type counterparts with regard to the efficiency of
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FIG. 1. The thiol-disulfide exchange reaction. Cartoon de-
picting the mechanism of thiol-disulfide exchange between a
reduced (SH) and a disulfide-linked (S-S) cysteine pair (e.g.,
residing on two separate proteins). Upon deprotonation of
one of the cysteinyl thiol groups, the resulting thiolate anion
nucleophilically attacks one of the disulfide-bound sulfur
atoms, leading to the formation of a mixed-disulfide complex.
Deprotonation of and nucleophilic attack by the second thiol
group then prompts the formerly reduced pair of cysteines to
form a disulfide bond. In the course of this redox reaction, two
electrons are transferred from the reductant to the oxidant in
exchange of two ‘‘oxidizing equivalents.’’
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FIG. 2. Disulfide relay from Ero1 via PDI to substrate
proteins. A disulfide bond is generated by the transfer of two
oxidizing equivalents from the flavin adenine dinucleotide
cofactor (shown as three black rings embedded between the
four Ero1 core a-helices, drawn as dark gray cylinders) to the
inner-active-site cysteine pair in Ero1 (step a). After the in-
tramolecular thiol-disulfide exchange reaction (see Fig. 1)
between inner and outer active site of Ero1 (step b), the
disulfide bond is transferred from the outer active site (lo-
cated within a flexible loop region in Ero1, depicted by a
sinuous black curve) to one of the two di-cysteine active sites
in PDI (step c). As a consequence, PDI is capable of intro-
ducing disulfide bonds into nascent polypeptides (dubbed
‘‘substrate’’) through thiol-disulfide exchange (step d). Ar-
rows denote the flow of two oxidizing equivalents; cysteine
pairs are depicted only by their sulfur atoms (S); the four
thioredoxin-like domains in PDI are represented by gray
circles. Ero1, endoplasmic oxidoreductin 1; PDI, protein
disulfide isomerase.
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oxidative folding of immunoglobulin M (IgM) (55, 56). With
one known exception (the oxidative folding of proinsulin in the
b-cells of the pancreas, discussed further below), it is therefore
reasonable to assume that the overall pace of disulfide-bond
formation is not severely compromised in ERO1L/ERO1LB
mutant mice and does not phenocopy the fatal situation in
Ero1p-deficient yeast cells.
These observations can be explained by alternative mech-
anisms for de novo disulfide-bond generation in the mamma-
lian ER (13) and/or by incomplete gene trapping, which
would allow the low-level synthesis of operational Ero1
molecules. Indeed, residual amounts of Ero1b were detected
onmRNA level in cardiomyocytes (16) and on protein level in
pancreatic tissue and LPS blasts from Ero1 double mutant
mice (55). In all cell types studied so far, only a minor portion
of Ero1a and, presumably, Ero1b is maintained in an active
form (6, 11, 16) (see also below). Consequently, when shifted
to increased activity through redox regulation, the residual
levels of Ero1b in ERO1L/ERO1LB compound mutant mice
might actually suffice to support disulfide-bond formation.
Along the same lines, yeast cells can proliferate in the presence
of very low amounts of Ero1p. Sufficient levels of Ero1p to
allow for growth of an ero1-null strain can be provided by a
plasmid encoding ERO1 under the control of a galactose-
inducible promoter even when cells are grown in glucose
(where the promoter is largely repressed) (Carolyn S. Sevier,
pers. comm.). It is therefore important to consider that the
designation of ERO1L/ERO1LB mutant mice as ‘‘knockout
animals’’ can provoke an underestimation of the functional
significance of Ero1 enzymes in mammals. Interestingly, the
high proliferation rate of immortalized mouse embryonic fi-
broblasts is profoundly affected by the ERO1L/ERO1LB
compound mutation (Ester Zito, David Ron, and Christian
Appenzeller-Herzog, unpublished observations), suggesting
that under in vitro conditions, normal levels of Ero1 enzymes
are required for optimal cell growth. On the other hand, flies
homozygous for a nonsense allele of their single ERO1L gene
develop almost normally (49), which strongly suggests the
existence of ERO1L-independent pathways for disulfide-bond
formation.
In addition, while both Ero1p and Ero1a (and, most likely,
Ero1b) are soluble ER proteins, which are peripherally
membrane-associated (14, 20, 42), only Ero1p possesses a
C-terminal membrane-targeting domain (43). Further differ-
ences between Ero1p and the mammalian Ero1 enzymes
include a distinct set of regulatory disulfide bonds for the
shutdown of oxidase activity and different mechanisms of
substrate recognition and oxidation. These issues will be
covered in subsequent sections.
Ero1 Enzymes Are Feedback-Regulated
Sulfhydryl Oxidases
Of note, not all of the cysteineswithin the primary sequence
of Ero1 are positionally conserved from yeast to mammals.
While the inner and outer active-site cysteines (Cys394-Cys397
and Cys94-Cys99 in human Ero1a) and the long-range dis-
ulfide connecting the two active-site peptides (Cys85-Cys391 in
Ero1a) are preserved, intramolecular disulfide bonds homol-
ogous to the regulatory Cys143-Cys166 and Cys150-Cys295 in
Ero1p are absent from both Ero1a and Ero1b (Fig. 3). Amino
acid substitution and mass spectrometry analysis revealed
that Ero1a in its most oxidized redox state forms a disulfide
bond between Cys94 and Cys131 (6, 10). As Cys94 is a constit-
uent of the outer active site, Cys94-Cys131 has to be resolved to
allow disulfide shuttling to PDI. Interestingly, also Cys99
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FIG. 3. Cysteine connectivity of oxidatively silenced Ero1 enzymes. Ero1a, Ero1b, and Ero1p polypeptides are depicted by
gray bars. Numbered dots represent the positions of cysteine residues within the respective Ero1 sequences, and brackets
connecting two dots show intramolecular disulfide bonds. Ero1a, Ero1b, and Ero1p possess two di-cysteine active sites (black
dots), the C-terminal inner active sites (Cys394 + 397, Cys393 + 396, Cys352 + 355) and the N-terminal outer active sites (Cys94+ 99,
Cys90+ 95, Cys100 + 105). Regulatory disulfides, which negatively control oxidase activity, are pictured by dark gray brackets.
Not all of the regulatory cysteines (dark gray) are positionally conserved between Ero1p and Ero1a/b, and disulfide linkages
between regulatory and outer-active-site cysteines only exist in the mammalian enzymes. Note that the functional coloring of
the long-range disulfide (Cys85-Cys391, Cys81-Cys390, Cys90-Cys349) and the cysteine connectivity of Ero1b is speculative at
present (see main text for details). Cysteines of structural or unknown function (light gray) are connected with dotted
brackets in case of disulfide-bond connection. Question marks denote that no conclusive redox state has been demonstrated,
yet. Ero1p possesses an additional C-terminal domain that is responsible for its tethering to the membrane (dark gray box).
For more detailed information regarding redox-state-dependent changes in the cysteine connectivity refer to the main text.
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forms a ‘‘nonactive-site’’ disulfide with Cys104 in the shut-off
state of Ero1a (10). Like Cys131, Cys104 has no equivalent in
Ero1p.
The identification of these new types of regulatory dis-
ulfide, which are likely to be present in Ero1b, too (53), has
implications for the redox-driven mechanisms of enzyme
(in)activation. Thus, in an oxidizing ER environment when
reduced substrates for Ero1a are scarce, newly produced
disulfide bonds arising from the inner active site will be
‘‘stored’’ as Cys94-Cys131 and Cys99-Cys104. Molecularly, a
likely scenario would be the nucleophilic attack of the shuttle
disulfide by Cys131 (giving rise to Cys94-Cys131) followed by
the transfer of a second disulfide from the inner active site via
the transient formation of Cys99-Cys394 [in analogy to Ero1p;
(47)], which is then resolved through nucleophilic attack by
Cys104. As to the reactivation under reducing conditions, the
situation is less straightforward. Two electrons are required to
break either of the two regulatory disulfide bonds, before the
shuttle disulfide can be reformed through nucleophilic attack.
The finding that the concentration of reduced PDI in the ER
influences the extent of Cys94-Cys131 formation suggests PDI
as the reductant (6). However, PDI has proven to be an inef-
fective activator of Ero1a in a reconstituted reaction (9, 10, 15,
52). In keeping with the predominantly inactive state of Ero1a
in the ER (6, 11, 16), this relative resistance of Ero1a toward
PDI-mediated reduction could be a critical determinant of ER
redox control rather than a manifestation of its poor catalytic
proficiency. Indeed, when the thiol load of the ER is maxi-
mized by treatment with a strong reducing agent, the Ero1a-
dependent re-formation of disulfides is exceptionally fast
upon washout of the reductant (7). These findings are con-
sistent with the concept that Ero1a is an environment-
dependent sulfhydryl oxidase, the activity of which is
governed by the redox state of its own substrate(s).
In contrast to the aforementioned disulfide bonds, the long-
range disulfide, which is conserved in all Ero1 orthologs, does
not involve any active-site cysteines (Fig. 3). Two alternative
views exist on the role of this disulfide during catalysis. Based
on the finding that purified Ero1a C85A-C104A-C131A-
C391A—although well-folded—is less active in an oxidase
assay than Ero1a C104A-C131A (9), one opinion holds that
Cys85-Cys391 must be intact for efficient substrate oxidation.
The second view, which we tend to favor, suggests a re-
arrangement of this disulfide during enzyme activation. Thus,
an as yet unidentified cysteinyl thiolate anion might attack,
for example, Cys85 and thereby free Cys391 to create a new
short-range disulfide in Ero1a that facilitates the communi-
cation between inner and outer active site. It can also be
speculated that the presumed isomerization reaction is not
readily triggered through intramolecular attack, but instead
catalyzed by a thiol-disulfide isomerase such as ERp44 or
another PDI that could initially resolve the long-range dis-
ulfide (for discussion of mixed-disulfide interactions of Ero1,
see below). In potential support of this second view, activated
Ero1a (10) and Ero1b (53) virtually co-migrate with the fully
reduced forms on nonreducing gels. In addition, presumably
catalytic mixed-disulfide complexes between Ero1a or Ero1b
and PDI trapped in living cells after treatment with a reduc-
tant display markedly decreased gel mobility—indicative of
long-range disulfide resolution—as compared with the com-
plexes trapped at steady state (7). Intriguingly, the crystal
structure of a hyperactive Ero1aC104A-C131Amutant, which
still harbors Cys85-Cys391, does not reveal any obvious path-
way for O2 to reach the protein-embedded FAD moiety (29).
We speculate that structural flexibility upon disruption of
Cys85-Cys391 will be instrumental for the emergence of such
an aqueous O2 channel. A detailed study on the reductive
activation of Ero1p has also indicated that a subfraction of the
long-range disulfide is resolved prior to the catalysis of sub-
strate oxidation (27).
Mechanisms of selection of specific
sulfhydryl substrates
Among the total of *20 PDI-like proteins in humans (5),
PDI itself has been shown to be the major substrate for Ero1-
mediated oxidation. Numerous cues in favor of this view exist
including data from both cell culture and in vitro assays (6, 7,
29, 53). Ero1a recognizes PDI by a lock-and-key principle ir-
respective of whether or not the redox-active cysteines are
present in PDI (29, 41). Thus, initial binding prior to the for-
mation of a catalytic mixed disulfide occurs through non-
covalent interactions. It has been conclusively demonstrated
that these interactions are of hydrophobic nature (29). They
involve a protruding b-hairpin in Ero1a, which contains a
critical tryptophan residue at its very tip (Trp272), and a hy-
drophobic cleft in the substrate-binding domain of PDI (36).
Even though experimental data were exclusively generated
with Ero1a, both the hairpin structure and the crucial trypto-
phan are present in Ero1b as well (Fig. 4). Accordingly, the
principle of substrate recognition is probably conserved among
the mammalian isoforms. In addition, as hinted by in silico
complex modeling (36), this mode of interaction presumably
facilitates the specific thiol-disulfide exchange between the C-
terminal active-site domain of PDI and the shuttle disulfide in
Ero1a (7, 9, 10, 15, 52). In contrast, Ero1p harbors no trypto-
phan-containing b-hairpin (25) and preferentially oxidizes the
N-terminal active-site domain of yeast PDI (51).
As opposed to the bona fide substrate PDI, its homolog ERp44
can efficiently bind to Ero1a even in the absence of the b-hairpin
(36). Further, equal amounts of ERp44—Ero1amixed disulfides
are detected with all single-cysteine mutants of Ero1a (12), in-
dicating that ERp44 can attack at least one disulfide other than
the shuttle disulfide with its active-site cysteine. Besides these,
also other PDI-family members—although inferior substrates
for oxidation (29, 53)—form mixed disulfides with Ero1a and
Ero1b within cells under steady-state conditions (7, 30, 46). As
pointed out for PDI (7), these complexes most likely involve an
oxidized (noncatalytic) form of Ero1a. In addition, they are not
strictly dependent on the presence of an intact shuttle disulfide
(7, 12) so that they might be formed in analogy to the ERp44–
Ero1a interaction. The physiological roles of these covalent
complexes are currently unclear.
Ero1a and Ero1b: Functional substitutes or brothers
in arms?
While the above sections have highlighted many shared
catalytic characteristics between Ero1a and Ero1b, the two
homologs have also diverged in a number of features. For
instance, the transcriptional regulation of ERO1L and
ERO1LB is different, which undoubtedly contributes to the
distinct expression profiles in human tissues (42) (Fig. 5). The
high Ero1b levels in insulin-producing b-cells of the pancreas
are maintained by the key pancreatic transcription factor
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PDX1 (31). The importance of Ero1b in these cells is high-
lighted by the finding that the oxidative maturation of pro-
insulin is delayed in pancreatic islets from ERO1LB mutant
mice, which manifests in a diabetic phenotype (55). Intrigu-
ingly, this phenotype is neither complemented by a com-
pensatory increase in Ero1a levels nor exacerbated by
additional mutation of ERO1L, which argues against redun-
dancy of Ero1 isoforms in the endocrine pancreas of mice (55).
ERO1LB is also a target of the ER-stress-responsive tran-
scription factor ATF6a (1) that is preferentially activated un-
der reducing ER conditions (39).
ERO1L, on the other hand, is a transcriptional target of
HIF1a that is upregulated in response to hypoxia or hypo-
glycemia (23, 37). Indeed, Ero1a is instrumental in counter-
acting ER hypo-oxidation brought about by hypoxic
treatment of cells (16). In addition, the expression of ERO1L is
enhanced during adipogenesis, which depends on the nuclear
hormone receptor peroxisome proliferator-activated receptor
gamma (PPARc) (45). Finally, Ero1a is induced during a late
stage of ER stress signaling through the binding of C/EBP
homologous protein (CHOP; also known as Gadd153) to its
promotor (34) (see below).
Ectopic expression of Ero1b—in contrast to Ero1a that has no
discernible effect—moderately increases the oxidation of ER
oxidoreductases and glutathione (6). This is likely owing to the
relative lability of the regulatory disulfide bonds in Ero1b, since
mutation of Cys100 and Cys130 in Ero1b does not activate the
purified enzyme to the same extent as the equivalentmutations
in Ero1a (53). Further, wild-type Ero1b shows higher rates of
oxygen consumption during in vitro substrate oxidation com-
pared with Ero1a (53). At the same time, however, the initial
slope of glutathione re-oxidation after complete chemical re-
duction is less pronounced in Ero1b- than in Ero1a-over-
expressing cells (7). Thus, the catalytic turnover rates of Ero1a
and Ero1b differ in a context-dependent manner.
Can these disparities be explained at the molecular level?
One of the two intercalating amino acids between the inner
active-site cysteines in Ero1a and Ero1b is different (Fig. 4).
When mutated to the Ero1b active-site sequence, the catalytic
turnover number of Ero1a increases (53). Moreover, Ero1b
harbors an additional cysteine at position 262 (Fig. 4), which
has been proposed to form a unique type of regulatory dis-
ulfide together with Cys100 (53). However, as predictable by
homology to Ero1a, Cys262 is located at the end of one of the
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FIG. 4. Annotated sequence alignment of human Ero1a and Ero1b. The aligned amino acid sequences are shown in single
letter code. Both proteins possess an N-terminal ER-targeting signal peptide (light gray boxes; predicted by the SignalP 3.0
program available at www.cbs.dtu.dk/services/SignalP), an inner and outer di-cysteine active site (gray boxes), four core a -
helices (marked by coiled hairlines above the sequence) and a tryptophan (white)-containing b-hairpin (dark gray box) that is
crucial for the interaction with PDI. Cysteine residues are highlighted by black-framed boxes, and asparagine residues within
N-glycosylation consensus sites by bold letters and the attachment of a schematized high-mannose oligosaccharide. Numbers
next to cysteines, N-glycosylation sites, and the PDI-binding tryptophan show the respective position in the amino acid
sequence. ER, endoplasmic reticulum.
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four core a-helices and immediately upstream of the PDI-
interacting b-hairpin loop (Fig. 4). We therefore consider it
unlikely that this region adopts a fundamentally different
conformation in Ero1b. In a structural homology model, the
side chain of Cys262 is located*30 A˚ away from Cys100 and
buried in the structure (data not shown). Finally, Ero1b har-
bors three unique N-glycosylation sites in the peptide sur-
rounding Cys130 (Fig. 4). In the model, the glycosylated
asparagines are solvent exposed and positioned between the
PDI-binding site and the shuttle disulfide (data not shown),
raising the possibility that substrate recruitment might be
modulated by the presence of bulky oligosaccharides. Over-
all, Ero1b—basally expressed at low levels (Fig. 5) and an
early target of the ER stress response (1)—represents an ef-
fective stress oxidase that can counteract ER hypo-oxidation.
Ero1a, on the other hand, likely fulfills a tightly regulated
housekeeping function with regard to disulfide generation.
Whether and to what extent the two isoforms functionally
and/or physically interact in tissues where they are co-
expressed remains to be examined.
Ero1a Is Critical for ER-Stress-Induced Apoptosis
Besides the regulated production of disulfides, Ero1a has
additional roles. A major fraction of Ero1amolecules localizes
to so-called mitochondria-associated membranes (MAMs), a
subdomain of the ER that is tethered to mitochondria (3, 24).
When activated by exogenous reductants or under hypoxic
conditions, Ero1a relocates to the bulk of the ER (24), sug-
gesting that its function at the MAMmight be independent of
its activity as an oxidase. The excitable calcium channels of the
inositol 1,4,5-trisphosphate receptor (IP3R) family are also
enriched in MAMs, and IP3R-facilitated calcium shuttling to
cytosol and mitochondria is a critical branch of apoptotic cell
death signaling during severe ER stress (17). One of the
switches that positively regulate such calcium flow is Ero1a
(32), which is induced by the ER stress-dependent, apopto-
genic transcription factor CHOP (34). Since the channeling
activity of IP3R subtype 1 is impeded by reversible binding of
ERp44 (28), elevated levels of Ero1a—a preferred ligand of
ERp44 (2, 36)—likely activate IP3R1 during ER stress by se-
questering ERp44 (in analogy to the mechanism described in
the next section). Conversely and similar to the knockdown of
IP3R1, silencing of Ero1a in macrophages inhibits ER-stress-
induced apoptosis by lowering ER calcium release (32). Re-
cently, knockdown of Ero1a in HeLa cells has been demon-
strated to predominantly hamper the accumulation of calcium
in mitochondria upon stimulation of IP3Rs (and only mar-
ginally in the cytosol), which is in agreement with the en-
richment of Ero1a in MAMs (3).
An alternative, although less plausible possibility is that
Ero1a does not enhance IP3R1 activity by lowering the
availability of ERp44 but by hyperoxidizing the ER. The in-
hibitory association with ERp44 depends on two reduced
cysteinyl thiols in IP3R1 (28), the oxidation of which upon ER
stress could consequently lead to channel activation. In
FIG. 5. Tissue-specific mRNA levels of human ERO1L and ERO1LB. Expression levels of ERO1L and ERO1LB mRNAs
(encoding Ero1a and Ero1b, respectively) in a range of human tissues shown as signal intensity on Affymetrix Human Genome
U133A array (probe sets: 218498_s_at for ERO1L and 220012_at for ERO1LB). The figure was generated with all available
datasets using the Genevestigator software (www.genevestigator.com/gv). The signal intensity on the abscissa is expressed on
an arbitrary, logarithmic scale. The abundance of ERO1L mRNA is overall higher than that of ERO1LB. ERO1LB expression
peaks in the stomach, the testis, and the pancreatic islets of Langerhans (highlighted with dark gray boxes). In contrast, elevated
levels of ERO1L mRNA can be detected especially in tonsils, oral region, and oesophagus (highlighted with light gray boxes).
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potential support of this, antioxidant treatment mimicked the
inhibitory effect of Ero1a knockdown on ER calcium release
(32). However, as the CHOP–Ero1a–IP3R1 signaling pathway
induces NADPH oxidase 2-derived reactive oxygen species
(ROS), which in turn further amplify CHOP (33), the appli-
cation of antioxidants did not necessarily exert its effect
by counteracting Ero1a activity. Moreover, given the tight
regulatory mechanisms that prevent excessive disulfide and
H2O2 synthesis by Ero1a (see above), its increased expression
does not per se hyperoxidize the ER (6, 7). The probably
minor contribution of Ero1-derived ROS to ER-stress-
induced cell death has recently been evaluated in detail
elsewhere (4).
Role of Ero1a in ERp44-Mediated ER Retention/Retrieval
Apart from their involvement in calcium signaling, Ero1a
and ERp44 orchestrate the secretion of diverse disulfide-
linked dimers and higher order oligomers by the reversible
formation of mixed-disulfide ERp44–protein adducts (Fig. 6).
ERp44 binds to substrates via its nonclassical CXXS active-site
motif (2), which lacks a resolving cysteine and therefore ren-
ders these intermolecular disulfide adducts longer-lived than
typical catalytic complexes. Moreover, despite its C-terminal
ER retrieval signal ERp44 is atypically enriched in the ER-
Golgi intermediate compartment (ERGIC)/cis-Golgi (35, 54),
which favors a model in which ERp44 retrieves substrates
from ERGIC/cis-Golgi to ER.
What is the role of Ero1a in the intracellular retention of
secretory proteins? Increased expression of Ero1a displaces
ERp44 from most of its endogenous substrates (2), indicating
it to be a preferred mixed-disulfide ligand of ERp44. Ac-
cordingly, the secretion of ERp44 retention substrates such as
IgM (2), the adipose-derived hormone adiponectin (54), or
sulfatase modifying factor 1 (SUMF1; also known as for-
mylglycine-generating enzyme) (19, 35) is enhanced upon
overexpression of Ero1a (Fig. 6). In the case of adipocytes,
endogenous induction of Ero1a by PPARc agonists is physi-
ologically relevant during differentiation and stimulation (45,
54). Although speculative, vascular endothelial growth factor
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FIG. 6. Interplay between Ero1a and ERp44 governs the secretion of various disulfide-linked dimers/oligomers. ERp44
mediates ER retention or retrieval from ERGIC/cis-Golgi of various immature monomers destined for dimerization/oligo-
merization and secretion. In this process, substrate binding by ERp44 is stabilized by formation of an interchain disulfide
bond involving Cys29 in ERp44. Upon exogenous overexpression or endogenous induction, Ero1a can—most likely by a
competitive mechanism—displace these substrates from ERp44, thus promoting their maturation into disulfide-linked pro-
tein complexes and subsequent secretion. In addition to the known ERp44 substrates IgM, SUMF1, and adiponectin, VEGF
displays similar properties, rendering it a potential ERp44 substrate (as indicated by the question marks). While the cysteine
residues responsible for ERp44-association and oligomerization have been identified in the substrate proteins, it is still
unclear, whether a specific cysteine in Ero1a is involved or Ero1a acts as a multivalent mixed-disulfide partner of ERp44
(question mark). The graphical depiction of the structure of the mature IgM pentamer (that contains two heavy and two light
chains per monomer) is simplified, and the existence of alternative oligomers (involving a J-chain) is neglected. The N-
terminal domains of the adiponectin trimer form a collagen-like triple helix that can dimerize (or multimerize, not shown)
through Cys36-mediated interchain disulfide-bond formation. Regarding SUMF1, it is important to point out that the drawn
mechanism of Ero1a-induced secretion only applies to overexpressed protein (endogenous SUMF1 is an ER-resident en-
zyme). Cysteine residues are represented only by their sulfur atoms, S; numbers, where indicated, show the position of the
cysteine in the human amino acid sequence. ERGIC, ER-Golgi intermediate compartment; IgM, immunoglobulin M; SUMF1,
sulfatase modifying factor 1; VEGF, vascular endothelial growth factor.
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(VEGF) might also add to the list of ERp44 substrates, as its
secretion, which is prominent in hypoxic tumors, is positively
regulated by Ero1a (37) (Fig. 6).
All secretory ERp44 substrates identified so far (and VEGF)
undergo cysteine-dependent dimerization/oligomerization
to be secreted. The cysteines engaged in this process have, in
case of retention, previously been linked to ERp44 (Fig. 6),
which is consistent with the concept that ERp44 traps in-
completely assembled subunits. Although this concept is
commonly referred to as ‘‘thiol-mediated retention,’’ it is
still unclear how these trapping interactions are formed. As
ERp44 comprises a single-cysteine active site, the oxidizing
equivalents to join two thiol groups would either have to
be contributed by the binding partner (e.g., through an
intramolecular disulfide or glutathionylation) or by ERp44
itself. The latter possibility could involve a disulfide-linked
homodimer or a heterodimer composed of Ero1a and ERp44.
However, as detailed above, abundant Ero1a–ERp44 com-
plexes rather inhibit than promote ‘‘thiol-mediated retention.’’
Conclusions and Perspectives
Ero1 enzymes are an integral part in our understanding of
redox maintenance in the ER. The two mammalian isoforms,
which differ from the yeast enzyme in a number of aspects,
fulfill similar roles in regulated disulfide production, but also
display distinctive features. While recent work has begun to
link these features to isoform-specific in vivo functions, there is
certainly more room for discovery regarding the physiologi-
cal roles of Ero1a and Ero1b. An eminent question for the
future is how redundant these roles are in mammals. Given
the viability of ERO1L/ERO1LB gene trap mice that still har-
bor detectable levels of the stress oxidase Ero1b (55), it is
possible that Ero1b can largely substitute for Ero1a deficiency.
Motivated by the finding that cardiomyocytes show de-
creased excitability due to lowered calcium transients in
ERO1L mutant mice (16), however, it will be important to
more closely look at, for example, ER-stress-induced apo-
ptosis or the secretion of ERp44 substrates in these mice.
Moreover, the question whether ERO1L/ERO1LB knockout
mice are also viable remains to be answered.
Since the reduction of O2 by Ero1 oxidases produces cyto-
toxic H2O2 in the ER, the function of ER-resident H2O2-
degrading peroxidases and their crosstalk with the PDI family
are likely to be fundamental (4, 13). For instance, the activity
of peroxiredoxin IV can produce disulfides and channel them
into oxidative folding (56). As for Ero1-derived H2O2, it will
be most interesting to carry out loss-of-function analyses with
two other PDI peroxidases, GPx7 and GPx8, which physically
interact with Ero1a (40).
Many additional features of mammalian Ero1 enzymes still
require further investigation. The functional significance of
covalent Ero1 dimerization (18) that apparently involves
Cys166 in Ero1a (29) is completely obscure. Likewise, the
molecular basis of membrane association of Ero1a is not
known, and it remains to be clarified whether its ER reten-
tion/MAM localization is mostly mediated by interaction
with the ER membrane (14, 42) or with ERp44 and other PDI
family members (41). In addition, the conservation among
metazoans of the N-terminal segment including two dis-
ulfides in Ero1a (but not Ero1b, Fig. 3) suggests some as yet
enigmatic function for this stretch of amino acids. It will also
be instrumental to molecularly describe the mode(s) of inter-
action between Ero1a and ERp44 including the cysteine con-
nectivities and subcellular localization of the complex (ER,
ERGIC, or MAM) and compare it to the complex involving
PDI (36). Since the catalytic Ero1a–PDI interaction plays a
critical role during the PDI-assisted translocation of the
cholera toxin A1 subunit from the ER to the cytosol (38), it also
remains to be explored, if endogenous ER-associated degra-
dation substrates require this interplay. Further, the mecha-
nism of redox-driven activation of Ero1a/b remains to be
elucidated, which—in conjunctionwith the aforementioned—
will set the stage for more exciting Ero1 news in the future.
Acknowledgments
We thank Lars Ellgaard for comments on the article. Work
in the authors’ laboratory is funded by the Swiss National
Science Foundation, the University of Basel, and the August
Collin-Fonds. T.R. is a recipient of a Ph.D. fellowship by the
Boehringer Ingelheim Fonds.
References
1. Adachi Y, Yamamoto K, Okada T, Yoshida H, Harada A,
and Mori K. ATF6 is a transcription factor specializing in the
regulation of quality control proteins in the endoplasmic
reticulum. Cell Struct Funct 33: 75–89, 2008.
2. Anelli T, Alessio M, Bachi A, Bergamelli L, Bertoli G, Ca-
merini S, Mezghrani A, Ruffato E, Simmen T, and Sitia R.
Thiol-mediated protein retention in the endoplasmic reticu-
lum: the role of ERp44. EMBO J 22: 5015–5022, 2003.
3. Anelli T, Bergamelli L, Margittai E, Rimessi A, Fagioli C,
Malgaroli A, Pinton P, Ripamonti M, Rizzuto R, and Sitia R.
Ero1a regulates Ca2 + fluxes at the endoplasmic reticulum-
mitochondria interface (MAM). Antioxid Redox Signal 16:
1077–1087, 2012.
4. Appenzeller-Herzog C. Glutathione- and non-glutathione-
based oxidant control in the endoplasmic reticulum. J Cell
Sci 124: 847–855, 2011.
5. Appenzeller-Herzog C and Ellgaard L. The human PDI
family: versatility packed into a single fold. Biochim Biophys
Acta 1783: 535–548, 2008.
6. Appenzeller-Herzog C, Riemer J, Christensen B, Sorensen
ES, and Ellgaard L. A novel disulphide switch mechanism in
Ero1alpha balances ER oxidation in human cells. EMBO J 27:
2977–2987, 2008.
7. Appenzeller-Herzog C, Riemer J, Zito E, Chin KT, Ron D,
Spiess M, and Ellgaard L. Disulphide production by
Ero1alpha-PDI relay is rapid and effectively regulated.
EMBO J 29: 3318–3329, 2010.
8. Araki K and Inaba K. Structure, mechanism and evolution of
Ero1 family enzymes. Antioxid Redox Signal 16: 790–799,
2012.
9. Araki K and Nagata K. Functional in vitro analysis of ERO1
and protein-disulfide isomerase (PDI) pathway. J Biol Chem
286: 32705–32712, 2011.
10. Baker KM, Chakravarthi S, Langton KP, Sheppard AM, Lu
H, and Bulleid NJ. Low reduction potential of Ero1alpha
regulatory disulphides ensures tight control of substrate
oxidation. EMBO J 27: 2988–2997, 2008.
11. Benham AM, Cabibbo A, Fassio A, Bulleid N, Sitia R, and
Braakman I. The CXXCXXC motif determines the folding,
structure and stability of human Ero1-Lalpha. EMBO J 19:
4493–4502, 2000.
1116 RAMMING AND APPENZELLER-HERZOG
12. Bertoli G, Simmen T, Anelli T, Molteni SN, Fesce R, and Sitia
R. Two conserved cysteine triads in human Ero1alpha co-
operate for efficient disulfide bond formation in the endo-
plasmic reticulum. J Biol Chem 279: 30047–30052, 2004.
13. Bulleid NJ and Ellgaard L. Multiple ways to make disulfides.
Trends Biochem Sci 36: 485–492, 2011.
14. Cabibbo A, Pagani M, Fabbri M, Rocchi M, Farmery MR,
Bulleid NJ, and Sitia R. ERO1-L, a human protein that favors
disulfide bond formation in the endoplasmic reticulum. J
Biol Chem 275: 4827–4833, 2000.
15. Chambers JE, Tavender TJ, Oka OB, Warwood S, Knight D,
and Bulleid NJ. The reduction potential of the active site
disulfides of human protein disulfide isomerase limits oxi-
dation of the enzyme by Ero1alpha. J Biol Chem 285: 29200–
29207, 2010.
16. Chin KT, Kang G, Qu J, Gardner LB, Coetzee WA, Zito E,
Fishman GI, and Ron D. The sarcoplasmic reticulum luminal
thiol oxidase ERO1 regulates cardiomyocyte excitation-
coupled calcium release and response to hemodynamic load.
FASEB J 25: 2583–2591, 2011.
17. Decuypere JP, Monaco G, Bultynck G, Missiaen L, De Smedt
H, and Parys JB. The IP(3) receptor-mitochondria connection
in apoptosis and autophagy. Biochim Biophys Acta 1813:
1003–1013, 2011.
18. Dias-Gunasekara S, Gubbens J, van Lith M, Dunne C, Wil-
liams JA, Kataky R, Scoones D, Lapthorn A, Bulleid NJ, and
Benham AM. Tissue-specific expression and dimerization of
the endoplasmic reticulum oxidoreductase Ero1beta. J Biol
Chem 280: 33066–33075, 2005.
19. Fraldi A, Zito E, Annunziata F, Lombardi A, Cozzolino M,
Monti M, Spampanato C, Ballabio A, Pucci P, Sitia R, and
Cosma MP. Multistep, sequential control of the trafficking
and function of the multiple sulfatase deficiency gene
product, SUMF1 by PDI, ERGIC-53 and ERp44. Hum Mol
Genet 17: 2610–2621, 2008.
20. Frand AR and Kaiser CA. The ERO1 gene of yeast is re-
quired for oxidation of protein dithiols in the endoplasmic
reticulum. Mol Cell 1: 161–170, 1998.
21. Frand AR and Kaiser CA. Ero1p oxidizes protein disulfide
isomerase in a pathway for disulfide bond formation in the
endoplasmic reticulum. Mol Cell 4: 469–477, 1999.
22. Frand AR and Kaiser CA. Two pairs of conserved cysteines
are required for the oxidative activity of Ero1p in protein
disulfide bond formation in the endoplasmic reticulum. Mol
Biol Cell 11: 2833–2843, 2000.
23. Gess B, Hofbauer KH, Wenger RH, Lohaus C, Meyer HE,
and Kurtz A. The cellular oxygen tension regulates expres-
sion of the endoplasmic oxidoreductase ERO1-Lalpha. Eur J
Biochem 270: 2228–2235, 2003.
24. Gilady SY, Bui M, Lynes EM, Benson MD, Watts R, Vance
JE, and Simmen T. Ero1alpha requires oxidizing and nor-
moxic conditions to localize to the mitochondria-associated
membrane (MAM). Cell Stress Chaperones 15: 619–629, 2010.
25. Gross E, Kastner DB, Kaiser CA, and Fass D. Structure of
Ero1p, source of disulfide bonds for oxidative protein fold-
ing in the cell. Cell 117: 601–610, 2004.
26. Gross E, Sevier CS, Heldman N, Vitu E, Bentzur M, Kaiser
CA, Thorpe C, and Fass D. Generating disulfides enzymat-
ically: reaction products and electron acceptors of the en-
doplasmic reticulum thiol oxidase Ero1p. Proc Natl Acad Sci
U S A 103: 299–304, 2006.
27. Heldman N, Vonshak O, Sevier CS, Vitu E, Mehlman T,
and Fass D. Steps in reductive activation of the disulfide-
generating enzyme Ero1p. Protein Sci 19: 1863–1876, 2010.
28. HigoT,HattoriM,NakamuraT,NatsumeT,MichikawaT, and
Mikoshiba K. Subtype-specific and ER lumenal environment-
dependent regulation of inositol 1,4,5-trisphosphate receptor
type 1 by ERp44. Cell 120: 85–98, 2005.
29. Inaba K, Masui S, Iida H, Vavassori S, Sitia R, and Suzuki M.
Crystal structures of human Ero1alpha reveal the mecha-
nisms of regulated and targeted oxidation of PDI. EMBO J
29: 3330–3343, 2010.
30. Jessop CE, Watkins RH, Simmons JJ, Tasab M, and Bulleid
NJ. Protein disulphide isomerase family members show
distinct substrate specificity: P5 is targeted to BiP client
proteins. J Cell Sci 122: 4287–4295, 2009.
31. Khoo C, Yang J, Rajpal G, Wang Y, Liu J, Arvan P, and
Stoffers DA. Endoplasmic reticulum oxidoreductase-1-Like
{beta} (ERO1l{beta}) regulates susceptibility to endoplasmic
reticulum stress and is induced by insulin flux in {beta}-cells.
Endocrinology 152: 2599–2608, 2011.
32. Li G, Mongillo M, Chin KT, Harding H, Ron D, Marks AR,
and Tabas I. Role of ERO1-alpha-mediated stimulation of
inositol 1,4,5-triphosphate receptor activity in endoplasmic
reticulum stress-induced apoptosis. J Cell Biol 186: 783–792,
2009.
33. Li G, Scull C, Ozcan L, and Tabas I. NADPH oxidase links
endoplasmic reticulum stress, oxidative stress, and PKR
activation to induce apoptosis. J Cell Biol 191: 1113–1125,
2010.
34. Marciniak SJ, Yun CY, Oyadomari S, Novoa I, Zhang Y,
Jungreis R, Nagata K, Harding HP, and Ron D. CHOP in-
duces death by promoting protein synthesis and oxidation
in the stressed endoplasmic reticulum. Genes Dev 18: 3066–
3077, 2004.
35. Mariappan M, Radhakrishnan K, Dierks T, Schmidt B, and
von Figura K. ERp44 mediates a thiol-independent retention
of formylglycine-generating enzyme in the endoplasmic re-
ticulum. J Biol Chem 283: 6375–6383, 2008.
36. Masui S, Vavassori S, Fagioli C, Sitia R, and Inaba K. Mo-
lecular bases of cyclic and specific disulfide interchange
between human ERO1{alpha} protein and protein-disulfide
isomerase (PDI). J Biol Chem 286: 16261–16271, 2011.
37. May D, Itin A, Gal O, Kalinski H, Feinstein E, and Keshet E.
Ero1-L alpha plays a key role in a HIF-1-mediated pathway
to improve disulfide bond formation and VEGF secretion
under hypoxia: implication for cancer. Oncogene 24: 1011–
1020, 2005.
38. Moore P, Bernardi KM, and Tsai B. The Ero1alpha-PDI
redox cycle regulates retro-translocation of cholera toxin.
Mol Biol Cell 21: 1305–1313, 2010.
39. Nadanaka S, Okada T, Yoshida H, and Mori K. Role of
disulfide bridges formed in the luminal domain of ATF6 in
sensing endoplasmic reticulum stress. Mol Cell Biol 27: 1027–
1043, 2007.
40. Nguyen VD, Saaranen MJ, Karala AR, Lappi AK, Wang L,
Raykhel IB, Alanen HI, Salo KE, Wang CC, and Ruddock
LW. Two endoplasmic reticulum PDI peroxidases increase
the efficiency of the use of peroxide during disulfide bond
formation. J Mol Biol 406: 503–515, 2011.
41. Otsu M, Bertoli G, Fagioli C, Guerini-Rocco E, Nerini-
Molteni S, Ruffato E, and Sitia R. Dynamic retention of
Ero1alpha and Ero1beta in the endoplasmic reticulum by
interactions with PDI and ERp44. Antioxid Redox Signal 8:
274–282, 2006.
42. Pagani M, Fabbri M, Benedetti C, Fassio A, Pilati S, Bulleid
NJ, Cabibbo A, and Sitia R. Endoplasmic reticulum oxidor-
eductin 1-lbeta (ERO1-Lbeta), a human gene induced in the
ERO1 FAMILY ENZYMES IN MAMMALS 1117
course of the unfolded protein response. J Biol Chem 275:
23685–23692, 2000.
43. Pagani M, Pilati S, Bertoli G, Valsasina B, and Sitia R. The C-
terminal domain of yeast Ero1p mediates membrane locali-
zation and is essential for function. FEBS Lett 508: 117–120,
2001.
44. Pollard MG, Travers KJ, and Weissman JS. Ero1p: a novel
and ubiquitous protein with an essential role in oxidative
protein folding in the endoplasmic reticulum. Mol Cell 1:
171–182, 1998.
45. Qiang L, Wang H, and Farmer SR. Adiponectin secretion is
regulated by SIRT1 and the endoplasmic reticulum oxido-
reductase Ero1-L alpha. Mol Cell Biol 27: 4698–4707, 2007.
46. Schulman S, Wang B, Li W, and Rapoport TA. Vitamin K
epoxide reductase prefers ER membrane-anchored thior-
edoxin-like redox partners. Proc Natl Acad Sci U S A 107:
15027–15032, 2010.
47. Sevier CS and Kaiser CA. Disulfide transfer between two
conserved cysteine pairs imparts selectivity to protein oxi-
dation by Ero1. Mol Biol Cell 17: 2256–2266, 2006.
48. Sevier CS, Qu H, Heldman N, Gross E, Fass D, and Kaiser
CA. Modulation of cellular disulfide-bond formation and the
ER redox environment by feedback regulation of Ero1. Cell
129: 333–344, 2007.
49. Tien AC, Rajan A, Schulze KL, Ryoo HD, Acar M, Steller H,
and Bellen HJ. Ero1L, a thiol oxidase, is required for Notch
signaling through cysteine bridge formation of the Lin12-
Notch repeats in Drosophila melanogaster. J Cell Biol 182: 1113–
1125, 2008.
50. Tu BP, Ho-Schleyer SC, Travers KJ, and Weissman JS. Bio-
chemical basis of oxidative protein folding in the endoplas-
mic reticulum. Science 290: 1571–1574, 2000.
51. Vitu E, Kim S, Sevier CS, Lutzky O, Heldman N, Bentzur M,
Unger T, Yona M, Kaiser CA, and Fass D. Oxidative activity
of yeast Ero1p on protein disulfide isomerase and related
oxidoreductases of the endoplasmic reticulum. J Biol Chem
285: 18155–18165, 2010.
52. Wang L, Li SJ, Sidhu A, Zhu L, Liang Y, Freedman RB, and
Wang CC. Reconstitution of human Ero1-Lalpha/protein-
disulfide isomerase oxidative folding pathway in vitro.
Position-dependent differences in role between the a and a’
domains of protein-disulfide isomerase. J Biol Chem 284: 199–
206, 2009.
53. Wang L, Zhu L, and Wang CC. The endoplasmic reticulum
sulfhydryl oxidase Ero1beta drives efficient oxidative pro-
tein folding with loose regulation. Biochem J 434: 113–121,
2011.
54. Wang ZV, Schraw TD, Kim JY, Khan T, Rajala MW, Follenzi
A, and Scherer PE. Secretion of the adipocyte-specific se-
cretory protein adiponectin critically depends on thiol-
mediated protein retention.Mol Cell Biol 27: 3716–3731, 2007.
55. Zito E, Chin KT, Blais J, Harding HP, and Ron D. ERO1-beta,
a pancreas-specific disulfide oxidase, promotes insulin bio-
genesis and glucose homeostasis. J Cell Biol 188: 821–832,
2010.
56. Zito E, Melo EP, Yang Y, Wahlander A, Neubert TA, and Ron
D. Oxidative protein folding by an endoplasmic reticulum-
localized peroxiredoxin. Mol Cell 40: 787–797, 2010.
Address correspondence to:
Dr. Christian Appenzeller-Herzog
Division of Molecular and Systems Toxicology
Department of Pharmaceutical Sciences
University of Basel
Klingelbergstrasse 50
CH-4056 Basel
Switzerland
E-mail: christian.appenzeller@unibas.ch
Date of first submission to ARS Central, December 15, 2011;
date of acceptance, December 18, 2011.
Abbreviations Used
CHOP¼C/EBP homologous protein
ER¼ endoplasmic reticulum
ERGIC¼ER-Golgi intermediate compartment
Ero1¼ endoplasmic oxidoreductin 1
FAD¼flavin adenine dinucleotide
H2O2¼hydrogen peroxide
IgM¼ immunoglobulin M
IP3R¼ inositol 1,4,5-trisphosphate receptor
LPS¼ lipopolysaccharide
MAM¼mitochondria-associated membranes
O2¼molecular oxygen
PDI¼protein disulfide isomerase
PPARc¼peroxisome proliferator-activated
receptor gamma
ROS¼ reactive oxygen species
SUMF1¼ sulfatase modifying factor 1
VEGF¼vascular endothelial growth factor
1118 RAMMING AND APPENZELLER-HERZOG
This article has been cited by:
1. Benjamin A. Israel, Lingxi Jiang, Shawn A. Gannon, Colin Thorpe. 2014. Disulfide bond generation in mammalian blood serum:
detection and purification of quiescin-sulfhydryl oxidase. Free Radical Biology and Medicine 69, 129-135. [CrossRef]
2. Thomas Ramming, Henning G. Hansen, Kazuhiro Nagata, Lars Ellgaard, Christian Appenzeller-Herzog. 2014. GPx8 peroxidase
prevents leakage of H2O2 from the endoplasmic reticulum. Free Radical Biology and Medicine . [CrossRef]
3. András Szarka, Tamás Lőrincz. 2013. The role of ascorbate in protein folding. Protoplasma . [CrossRef]
4. Tino Prell, Janin Lautenschläger, Julian Grosskreutz. 2013. Calcium-dependent protein folding in amyotrophic lateral sclerosis.
Cell Calcium 54:2, 132-143. [CrossRef]
5. Shane Deegan, Svetlana Saveljeva, Adrienne M. Gorman, Afshin Samali. 2013. Stress-induced self-cannibalism: on the regulation
of autophagy by endoplasmic reticulum stress. Cellular and Molecular Life Sciences 70:14, 2425-2441. [CrossRef]
6. A. M. Benham, M. van Lith, R. Sitia, I. Braakman. 2013. Ero1-PDI interactions, the response to redox flux and the implications
for disulfide bond formation in the mammalian endoplasmic reticulum. Philosophical Transactions of the Royal Society B: Biological
Sciences 368:1617, 20110403-20110403. [CrossRef]
7. Davide Montero, Christine Tachibana, Jakob Rahr Winther, Christian Appenzeller-Herzog. 2013. Intracellular glutathione pools
are heterogeneously concentrated. Redox Biology 1:1, 508-513. [CrossRef]
8. Thomas Ramming, Christian Appenzeller-Herzog. 2013. Destroy and Exploit: Catalyzed Removal of Hydroperoxides from the
Endoplasmic Reticulum. International Journal of Cell Biology 2013, 1-13. [CrossRef]
9. Lloyd W. Ruddock. 2012. Low-Molecular-Weight Oxidants Involved in Disulfide Bond Formation. Antioxidants & Redox Signaling
16:10, 1129-1138. [Abstract] [Full Text HTML] [Full Text PDF] [Full Text PDF with Links]
10. Christian Appenzeller-Herzog, Michael N. Hall. 2012. Bidirectional crosstalk between endoplasmic reticulum stress and mTOR
signaling. Trends in Cell Biology 22:5, 274-282. [CrossRef]
11. Taichi Kakihana, Kazuhiro Nagata, Roberto Sitia. 2012. Peroxides and Peroxidases in the Endoplasmic Reticulum: Integrating
Redox Homeostasis and Oxidative Folding. Antioxidants & Redox Signaling 16:8, 763-771. [Abstract] [Full Text HTML] [Full
Text PDF] [Full Text PDF with Links]
12. Kazutaka Araki, Kenji Inaba. 2012. Structure, Mechanism, and Evolution of Ero1 Family Enzymes. Antioxidants & Redox Signaling
16:8, 790-799. [Abstract] [Full Text HTML] [Full Text PDF] [Full Text PDF with Links] [Supplemental Material]
